- 询价
- Biorbyt
- 英国
- orb1943769
- 2025年07月13日
企业认证
相关产品推荐更多 >
![6-Amino-4-hydrozino-2-(b-D-ribofuranosyl)-2H-pyrazolo[3,4-d]pyrimidine，orb1908659，Biorbyt](https://img1.dxycdn.com/p/s14/2024/0315/702/8676315543302258671.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
详询
- 保质期：
6-12个月
- 英文名：
Therapeutic agent-1
- 库存：
99
- 供应商：
Biorbyt
- CAS号：
850020-01-8
- 规格：
50 mg/5 mg
| 规格： | 50 mg | 产品价格： | 询价 |
|---|---|---|---|
| 规格： | 5 mg | 产品价格： | 询价 |
Therapeutic agent-1
产品名：Therapeutic agent-1
货号：orb1943769
产品中文名：Therapeutic agent-1
产品详情链接：https://www.biorbyt.com/therapeutic-agent-1-orb1943769.html
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Protein-based therapeutics are highly successful in clinic and currently enjoy unprecedented recognition of their potential. More than 100 genuine and similar number of modified therapeutic proteins are approved for clinical use
A brief historical introduction describes early attempts to silence specific genes using the antisense oligonucleotides that flourished in the 1980s. Early aspirations for therapeutic applications were almost extinguished by the unexpected
Telomerase as a Therapeutic Target: Therapeutic Potential of Telomerase Inhibitors
The most desirable properties of any therapeutic agent must be selectivity and potency (1 ). Of the two, potency is less critical, though in terms of potential administration it is important to recognize that patients should not be expected
技术资料暂无技术资料 索取技术资料
